MDCX — Medicus Pharma Cashflow Statement
0.000.00%
- $52.99m
- $47.68m
Annual cashflow statement for Medicus Pharma, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | R2022 December 31st | R2023 December 31st | 2024 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | USG | USG |
Status: | fx Final | fx Final | Final | Final | Final |
Net Income/Starting Line | -0.088 | -0.142 | -1.69 | -5.31 | -11.2 |
Non-Cash Items | 0 | — | 0.714 | 0.683 | 0.787 |
Unusual Items | |||||
Other Non-Cash Items | |||||
Changes in Working Capital | -0.058 | 0.059 | -0.079 | 0.473 | 0.121 |
Change in Prepaid Expenses | |||||
Change in Other Assets | |||||
Change in Accounts Payable | |||||
Change in Accrued Expenses | |||||
Change in Payable / Accrued Expenses | |||||
Cash from Operating Activities | -0.146 | -0.082 | -1.06 | -4.16 | -10.2 |
Financing Cash Flow Items | 0.224 | 0 | 0 | 5.11 | 0 |
Other Financing Cash Flow | |||||
Net Issuance / Retirement of Stock | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | 0.224 | 0 | 1.25 | 5.61 | 12.7 |
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | 0.078 | -0.082 | 0.189 | 1.45 | 2.44 |